Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment complete in EXPAND trial of Erbitux in gastric cancer

Jan. 7, 2011

Algeta completes enrollment into phase III Alpharadin trial

Jan. 7, 2011

SuperGen enrolls first patient in phase I SGI-110 trial in MDS and AML

Jan. 7, 2011

Novel B-raf inhibitors discovered at Nerviano Medical Sciences

Jan. 7, 2011

Mercator Therapeutics and Pepscan Therapeutics join to optimize anticancer homing peptides

Jan. 7, 2011

New inhibitors of FADK 1, JAK2 and JAK3 described

Jan. 7, 2011

Alnylam reports new phase I data on RNAi therapeutic ALN-VSP

Jan. 5, 2011

PharmaMar begins phase II trial of PM-00104 in Ewing's sarcoma

Jan. 5, 2011

Bayer begins phase II trial of BAY-86-9766 and sorafenib in liver cancer

Jan. 5, 2011

Isis Pharma launches phase II program for ISIS-EIF4ERx in cancer

Jan. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...